Asthma - Global Clinical Trials Review, 2026

Description

List of Tables

GlobalData's clinical trial report, "Asthma - Global Clinical Trials Review, 2026" provides an overview of Asthma Clinical trials scenario. This report provides top line data relating to the clinical trials on Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Product Code: GDHC7348CTIDB

List of Tables

List of Figures

Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Asthma to Respiratory Clinical Trials
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Asthma to Respiratory Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Asthma Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Asthma
Apr 28, 2026: Breztri approved in the US for asthma as first and only triple therapy for patients 12 years of age and older
Apr 17, 2026: Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
Apr 07, 2026: Sanofi's bispecific scores in respiratory diseases but fails in eczema
Apr 02, 2026: Sitryx Nominates Novel, Oral GLS1 Inhibitor for Clinical Development in Moderate to Severe Asthma
Mar 30, 2026: Enanta Pharmaceuticals to Present Data for Its STAT6 Inhibitor Program at IMMUNOLOGY2026, the Annual Meeting of the AAI
Mar 30, 2026: Connect Biopharma Announces Positive Topline Data from Its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD
Mar 22, 2026: Harbour Biomed Reports the Online Publication of Phase I Results for HBM9378 (SKB378/WIN378), a TSLP-Targeting Antibody
Mar 10, 2026: Pfizer's trispecific heads to Phase III on mid-stage AD success
Mar 05, 2026: CSPC Pharmaceutical Announces Indacaterol Acetate and Mometasone Furoate Powder For Inhalation Obtains Clinical Trial Approval in China
Mar 03, 2026: Vial Doses First Patient for Phase 1 Trial of Vial's IL-13 x TSLP, a Novel Bispecific Antibody
Feb 24, 2026: Aclaris Therapeutics Initiates Phase 1B Proof-Of-Concept Trial in Patients with Asthma with Its Novel Bispecific Anti-TSLP/Il-4ra Antibody ATI-052
Feb 18, 2026: GSK's AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe Flare-Ups of COPD and Asthma
Feb 13, 2026: Positive and Clinically Meaningful Results From Phase III Trials for Breztri in Patients With Asthma Published in Lancet Respiratory Medicine
Feb 12, 2026: Upstream Bio's stock drops 47% on verekitug Phase II asthma data
Feb 11, 2026: Akeso's IL-4Ra/ST2 Bispecific Antibody Cleared for Seven Phase II Studies in China Spanning Respiratory and Autoimmune Indications
Feb 10, 2026: Upstream Bio to Host Webcast to Report Top-Line Results from the Phase 2 VALIANT Trial of Verekitug in Patients with Severe Asthma
Jan 29, 2026: Kymera Therapeutics Announces First Patient Dosed in Breadth Phase 2B Asthma Clinical Trial of KT-621, a First-In-Class, Oral STAT6 Degrader
Clinical Trial Profile Snapshots

Appendix

Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Source

Product Code: GDHC7348CTIDB

List of Table

List of Tables

Asthma Therapeutics, Global, Clinical Trials by Region, 2026*
Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2026*
Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2026*
Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2026*
Asthma Therapeutics Clinical Trials, Europe, Top Five Countries, 2026*
Asthma Therapeutics Clinical Trials, North America, Top Countries, 2026*
Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2026*
Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2026*
Proportion of Asthma to Respiratory Clinical Trials, G7 Countries (%), 2026*
Asthma Therapeutics, G7 Countries, Clinical Trials by Phase, 2026*
Asthma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2026*
Proportion of Asthma to Respiratory Clinical Trials, E7 Countries (%), 2026*
Asthma Therapeutics, E7 Countries, Clinical Trials by Phase, 2026*
Asthma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2026*
Asthma Therapeutics, Global, Clinical Trials by Phase, 2026*
Asthma Therapeutics, Global, Clinical Trials In Progress by Phase 2026*
Asthma Therapeutics, Global, Clinical Trials by Trial Status, 2026*
Asthma Therapeutics Clinical Trials, Global, by End Point Status, 2026*
Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2021-2025
Asthma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2026*
Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2026*
Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2026*
Asthma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2026*

List of Figure

List of Figures

Asthma Therapeutics, Global, Clinical Trials by Region (%), 2026*
Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2026*
Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2026*
Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2026*
Asthma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2026*
Asthma Therapeutics Clinical Trials, North America, Top Countries (%), 2026*
Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2026*
Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2026*
Proportion of Asthma to Respiratory Clinical Trials, G7 Countries (%), 2026*
Asthma Therapeutics, G7 Countries, Clinical Trials by Phase, 2026*
Asthma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2026*
Proportion of Asthma to Respiratory Clinical Trials, E7 Countries (%), 2026*
Asthma Therapeutics, E7 Countries, Clinical Trials by Phase, 2026*
Asthma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2026*
Asthma Therapeutics, Global, Clinical Trials by Phase (%), 2026*
Asthma Therapeutics, Global, Clinical Trials In Progress by Phase, 2026*
Asthma Therapeutics, Global, Clinical Trials by Trial Status, 2026*
Asthma Therapeutics Clinical Trials, Global, by End Point Status, 2026*
Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2021-2025
Asthma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2026*
Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2026*
Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2026*
Asthma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2026*
GlobalData Methodology

Asthma - Global Clinical Trials Review, 2026

Description

Table of Contents

List of Tables

Scope

Reasons to Buy

Table of Contents

Table of Contents

List of Tables

List of Figures

Appendix

List of Table

List of Tables

List of Figure

List of Figures